658 results on '"Jardim Laura"'
Search Results
2. Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers.
3. The parkin V380L variant is a genetic modifier of Machado–Joseph disease with impact on mitophagy
4. Quantitative Oculomotor Assessment in Hereditary Ataxia: Discriminatory Power, Correlation with Severity Measures, and Recommended Parameters for Specific Genotypes.
5. Huntington disease: DNA analysis in brazilian population
6. Clinical and biochemical findings in 7 patients with X-linked adrenoleukodystrophy treated with Lorenzo's Oil
7. Machado Joseph-Disease Is Rare in the Peruvian Population
8. The longitudinal progression of MRI changes in pre-ataxic carriers of SCA3/MJD
9. Spinocerebellar ataxia type 2 has multiple ancestral origins
10. An Exploratory Survey on the Care for Ataxic Patients in the American Continents and the Caribbean
11. Diagnostic Delay of Hereditary Ataxias in Brazil: the Case of Machado-Joseph Disease
12. Equaliza\c{c}\~ao das escalas NESSCA e SARA utilizando a Teoria da Resposta ao Item na avalia\c{c}\~ao do comprometimento pela doen\c{c}a de Machado-Joseph
13. Cognitive-affective manifestations since premanifest phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease
14. Remote Measurement of Functional Status in Pre-symptomatic and Symptomatic Individuals with Machado-Joseph Disease
15. Quality of Life since Pre-Ataxic Phases of Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
16. Novel Machado-Joseph disease-modifying genes and pathways identified by whole-exome sequencing
17. The progression rate of spinocerebellar ataxia type 3 varies with disease stage
18. Variants in Genes of Calpain System as Modifiers of Spinocerebellar Ataxia Type 3 Phenotype
19. Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
20. Planning Future Clinical Trials for Machado-Joseph Disease
21. DNA damage and repair in individuals with ataxia-telangiectasia and their parents
22. Huntington's disease-like disorders in Latin America and the Caribbean
23. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study
24. Response to ATXN10 Microsatellite Distribution in a Peruvian Amerindian Population
25. Frequency and Genetic Profile of Compound Heterozygous Friedreich’s Ataxia Patients—the Brazilian Experience
26. ATXN10 Microsatellite Distribution in a Peruvian Amerindian Population
27. Ophthalmological and Neurologic Manifestations in Pre-clinical and Clinical Phases of Spinocerebellar Ataxia Type 7
28. Selective Forces Related to Spinocerebellar Ataxia Type 2
29. PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability
30. A model for the dynamics of expanded CAG repeat alleles: ATXN2 and ATXN3 as prototypes
31. BloodDDIT4andTRIM13transcript levels mark the early stages of Machado-Joseph disease
32. Spinocerebellar ataxia type 2 has multiple ancestral origins
33. A model for the dynamics of expanded CAG repeat alleles:ATXN2andATXN3as prototypes
34. Clinical and molecular characterization of hereditary spastic paraplegias: A next-generation sequencing panel approach
35. Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors
36. Friedreich Ataxia: Diagnostic Yield and Minimal Frequency in South Brazil
37. Oxidative Imbalance, Nitrative Stress, and Inflammation in C6 Glial Cells Exposed to Hexacosanoic Acid: Protective Effect of N-acetyl-l-cysteine, Trolox, and Rosuvastatin
38. Differences in spontaneous speech fluency between Parkinson's disease and spinocerebellar ataxia type 3
39. Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers
40. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial
41. Haplotype Study in SCA10 Families Provides Further Evidence for a Common Ancestral Origin of the Mutation
42. NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2
43. Dentatorubro-Pallidoluysian Atrophy (DRPLA) among 700 Families with Ataxia in Brazil
44. Reliability of speech assessments in spinocerebellar ataxia type 3/Machado-Joseph disease
45. Quantitative Oculomotor Assessment in Hereditary Ataxia: Discriminatory Power, Correlation with Severity Measures, and Recommended Parameters for Specific Genotypes
46. Planning Future Clinical Trials for Machado-Joseph Disease
47. Nonneurological Involvement in Late-Onset Friedreich Ataxia (LOFA): Exploring the Phenotypes
48. Non-motor and Extracerebellar Features in Spinocerebellar Ataxia Type 2
49. Pattern of Peripheral Nerve Involvement in Spinocerebellar Ataxia Type 2: a Neurophysiological Assessment
50. Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.